We write to provide an update on the Health Sciences Authority’s (“HSA”) proposed legislative amendments to Regulation 23 (“Reg 23”) of the Health Products (Therapeutic Products) Regulations 2016 (“TPR”).
Our Partner Jevon Louis and Senior Associate Kuek Kai Liang, discuss more in this client update.
Click here to view the article.
For further information, please contact:
Jevon Louis, Partner, Shook Lin & Bok
jevon.louis@shooklin.com
